Precision Medicine Is Critical for the Future of Oncology: Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on Theranostics, Imaging, and the Urgency to Innovate

By afschroeder • August 15, 2025

Behrenbruch C, Herrmann K, Czernin J. Precision Medicine Is Critical for the Future of Oncology: Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on Theranostics, Imaging, and the Urgency to Innovate. J Nucl Med. 2025 Aug 14:jnumed.125.270966. doi: 10.2967/jnumed.125.270966. Epub ahead of print. PMID: 40813237.

Tags: Cardiology/Epi, Publications

Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [177Lu]Lu-PSMA-617: A Single-Center Retrospective Study

Murthy V, Kimura K, Theus L, Nguyen A, Grogan TR, Lokre O, Perk T, Rettig MB, Drakaki A, Shen J, Thin P, Nguyen K, Lira[...]

New strategies for valve replacement and interventional options in adults with congenital heart disease: new insights from Euro-ACHD 2025

Butera G, Chessa M, Gaio G, Kempny A, Uebing A, Michielon G, Aboulhosn J, Giamberti A, Hoschtitzky A, d'Udekem Y. New strategies for valve replacement[...]

Navigating the Complexities of Carcinoid Heart Disease and Severe Coronary Artery Disease: A Case for Multidisciplinary Collaboration

Arbit B. Navigating the Complexities of Carcinoid Heart Disease and Severe Coronary Artery Disease: A Case for Multidisciplinary Collaboration. Cureus. 2025 Dec 23;17(12):e99940. doi: 10.7759/cureus.99940.[...]